Company Filing History:
Years Active: 2017-2020
Title: The Innovations of Stephan Albrecht Hahn
Introduction
Stephan Albrecht Hahn is a notable inventor based in Bochum, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the area of pancreatic disease. With a total of 2 patents, his work focuses on advancing the understanding and identification of pancreatic cancer.
Latest Patents
Hahn's latest patents include innovative methods and compositions involving miR-135b for distinguishing pancreatic cancer from benign pancreatic disease. These patents provide methods and compositions for identifying a miRNA profile for a particular condition, such as pancreatic disease, and using the profile in assessing the condition of a patient. This groundbreaking work has the potential to improve diagnostic accuracy and patient outcomes.
Career Highlights
Stephan Albrecht Hahn is currently associated with Interpace Diagnostics Corporation, where he continues to develop and refine his innovative approaches to medical diagnostics. His expertise in miRNA profiling has positioned him as a key figure in the ongoing research and development of diagnostic tools for pancreatic conditions.
Collaborations
Hahn has collaborated with notable colleagues, including Alex Adai and Bernard Andruss, to further enhance the impact of his research. These collaborations have fostered a dynamic environment for innovation and discovery in the field of medical diagnostics.
Conclusion
Stephan Albrecht Hahn's contributions to the field of pancreatic disease diagnostics exemplify the importance of innovation in medicine. His patents and ongoing work continue to pave the way for advancements that can significantly benefit patient care.